Evidence map›Paper›PMID 32581813›Full record

ArticleFrontiers in pharmacology2020

Antiplatelet Agents Have a Distinct Efficacy on Platelet Aggregation Induced by Infectious Bacteria.

Nadji Hannachi, Emma Ogé-Ganaye, Jean-Pierre Baudoin, Anthony Fontanini, Denis Bernot, Gilbert Habib, Laurence Camoin-Jau

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Platelet P2YBritish journal of pharmacology · 2024
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. The Role of Platelets in Infective Endocarditis.International journal of molecular sciences · 2023
    Review
  7. Effect of antiplatelet agents onFrontiers in microbiology · 2022
    Review
  8. Article
  9. Aspirin or Ticagrelor inFrontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Nadji HannachiAix Marseille Univ, IRD, APHM, MEPHI, IHU Méditerranée infection, Marseille, France.
Emma Ogé-GanayeAix Marseille Univ, IRD, APHM, MEPHI, IHU Méditerranée infection, Marseille, France.
Jean-Pierre BaudoinAix Marseille Univ, IRD, APHM, MEPHI, IHU Méditerranée infection, Marseille, France.
Anthony FontaniniAix Marseille Univ, IRD, APHM, MEPHI, IHU Méditerranée infection, Marseille, France.
Denis BernotLaboratoire d'Hématologie, Hôpital de la Timone, APHM, Boulevard Jean-Moulin, Marseille, France.
Gilbert HabibAix Marseille Univ, IRD, APHM, MEPHI, IHU Méditerranée infection, Marseille, France.
Laurence Camoin-JauAix Marseille Univ, IRD, APHM, MEPHI, IHU Méditerranée infection, Marseille, France.
Méditerranée Infection Foundation · FRAix-Marseille Université · FRHôpital Nord · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platelets are the cornerstone of hemostasis. However, their exaggerated aggregation induces deleterious consequences. In several diseases, such as infectious endocarditis and sepsis, the interaction between platelets and bacteria leads to platelet aggregation. Despite platelet involvement, no antiplatelet therapy is currently recommended in these infectious diseases. We aimed here, to evaluate,

Indexed as

aggregationantiplatelet agentsplateletsStaphylococcus aureusStreptococcus sanguinis

Identifiers

PMID32581813
PMCPMC7291881
OpenAlexW3033373090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.